According to the latest data from the Hong Kong Stock Exchange, on June 1st, CITIC SEC Asset Management Company sold 1.7752 million shares of SINOPHARM (01099).
The average selling price per share was approximately HK$16.9396, resulting in a total transaction value of about HK$30.0712 million.
Following this disposal, the asset manager's latest shareholding stands at approximately 146 million shares, representing a stake of 10.87%.
The transaction involved other related parties, specifically the CITIC Securities - Yunfan Single Asset Management Plan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments